|
生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
|
ヒト・動物細胞
|
RAW 264(RCB0535)
|
67643
|
Anti-Inflammatory Profile of Levosimendan in Cecal Ligation-Induced Septic Mice and in Lipopolysaccharide-Stimulated Macrophages.
|
Crit Care Med |
2015-11-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
Lu99(RCB1900)
,
RERF-LC-AI(RCB0444)
|
67417
|
Discovery of imidazo[1,2-b]pyridazine derivatives: selective and orally available Mps1 (TTK) kinase inhibitors exhibiting remarkable antiproliferative activity.
|
J Med Chem |
2015-2-26 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
KP4(RCB1005)
,
EBC-1(RCB1965)
|
66858
|
Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models.
|
Mol Cancer Ther |
2020-5-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
KP4(RCB1005)
|
64294
|
Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose.
|
CPT Pharmacometrics Syst Pharmacol |
2021-5-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
32Dcl3
|
61656
|
Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
|
Genes Chromosomes Cancer |
2016-1-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
Ba/F3(RCB0805)
|
44698
|
Targeting wild-type and mutationally activated FGFR4 in rhabdomyosarcoma with the inhibitor ponatinib (AP24534).
|
PLoS One |
2013-1-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
JHUEM-2(RCB1551)
|
44564
|
The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors.
|
Neoplasia |
2013-8-1 |
Pubmed
Full text
|
|
ヒト・動物細胞
|
LoVo(RCB1639)
,
HCT116(RCB2979)
|
44369
|
EMD 1214063 and EMD 1204831 constitute a new class of potent and highly selective c-Met inhibitors.
|
Clin Cancer Res |
2013-6-1 |
Pubmed
Full text
|